Biocon Sells 9.96% Stake In Contract Research Firm Syngene Via Open Market

Bengaluru-based Biocon had in September 2022 sold a 5.4% stake in the open market, as per an exchange filing

Topics

Biocon | biocon stock | Stake sale

Reuters  |  BENGALURU 



Biocon

The selling price would be in the range of 560 rupees and 562.30 rupees per share, the report said

').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();

BENGALURU (Reuters) - Indian biopharma company sold a 9.96% stake in its unit and contract research firm through open market sale, it said in an exchange filing on Wednesday.

With the sale, the total promoter stake of in Syngene stands at 54.6%, the exchange filing showed.

did not reveal the price at which the stake was sold.

Officials at Syngene and Biocon did not immediately respond to a Reuters query seeking the reason for the and the price at which the sale was executed.

Biocon was selling the stake in Syngene to fund the acquisition of Viatris Inc's biosimilars business that it announced last year, CNBC TV-18 reported on Tuesday.

The selling price would be in the range of 560 rupees and 562.30 rupees per share, the report said.

Biocon Biologics had in February 2022 said it would buy the U.S. drug maker's biosimilars business in a deal valued at $3.34 billion.

Bengaluru-based Biocon had in September 2022 sold a 5.4% stake in the open market, as per an exchange filing.

Biocon's shares closed up 2%, while those of Syngene added 0.74% on Wednesday.

 

(Reporting by Nallur Sethuraman in Bengaluru; Editing by Dhanya Ann Thoppil)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Subscribe to Business Standard Premium

Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!

First Published: Wed, February 01 2023. 19:33 IST


RECENT NEWS

Monzo Looks For US Banking License

Monzo is preparing a renewed push to secure a US banking licence, four years after abandoning its first attempt when tal... Read more

Crypto Firms Push Into US Banking

America’s cryptocurrency companies are scrambling to secure a foothold in the country’s traditional banking system, ... Read more

Parallel Banking: Stablecoins Are Now Global

Parallel Banking: How Stablecoins Are Building a New Global Payments SystemStablecoins—digital currencies pegged to tr... Read more

JPMorgan Deploys AI Chatbot To Revolutionize Research And Productivity

JPMorgan has deployed an AI-based research analyst chatbot to enhance productivity among its workforce, with approximate... Read more

Private Equity And Banks: The Complex Web Of Leverage

Private equity has emerged as a significant force in the global financial landscape, driving substantial growth and inve... Read more

Financial Watchdog Highlights Unresolved Vulnerabilities In Shadow Banking Sector

The world’s leading financial stability watchdog has issued a warning about the unresolved vulnerabilities within the ... Read more